Submissions for variant NM_000260.4(MYO7A):c.6614_6634dup (p.Met2205_Ser2211dup)

dbSNP: rs111033388

Total submissions: 7

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine	RCV000270443	SCV000204117	benign	not specified	2016-05-28	criteria provided, single submitter	clinical testing	c.6614_6634dup (p.Met2205_Ser221dup) in exon49 of MYO7A: This variant is not exp ected to have clinical significance because it has been identified in 2% (73/340 2) of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac .broadinstitute.org; dbSNP rs111033388).
Eurofins Ntd Llc (ga)	RCV000270443	SCV000336283	likely benign	not specified	2015-12-21	criteria provided, single submitter	clinical testing
GeneDx	RCV000881565	SCV000714127	likely benign	not provided	2022-05-24	criteria provided, single submitter	clinical testing	See Variant Classification Assertion Criteria.
Labcorp Genetics (formerly Invitae), Labcorp	RCV000881565	SCV001024751	benign	not provided	2025-02-02	criteria provided, single submitter	clinical testing
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)	RCV000881565	SCV001797652	likely benign	not provided		no assertion criteria provided	clinical testing
Clinical Genetics, Academic Medical Center	RCV000881565	SCV001923982	likely benign	not provided		no assertion criteria provided	clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center	RCV000881565	SCV001966665	likely benign	not provided		no assertion criteria provided	clinical testing